FDA Approved: LOTEPREDNOL ETABONATE — Supplemental Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

FDA approved a supplemental application for Loteprednol etabonate (Lotemax) by Bausch & Lomb Americas Inc., approving changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Inflammation of the Eye
• Postoperative Ocular Inflammation

Drugs mentioned

• Lotemax (Loteprednol etabonate)

Snippet

SUPPL AP for LOTEPREDNOL ETABONATE (LOTEPREDNOL ETABONATE)